drugset
drugset / Trial / NCT04952389

Acupuncture Therapy for COVID-Related Olfactory Loss

NCT04952389 ↗

Completed 30 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is looking at the role of acupuncture as a treatment for olfactory dysfunction in patients who tested positive for COVID-19.

Timeline

Start
2021-12-07
Primary completion
2023-04-21
Completion
2023-06-09

Drugs

EvaluationDrugModalityDoseRoute
Background Budesonide Small molecule — Intranasal

Indications

COVID-19 olfactory nerve disorder